Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Premature chain termination mutation causing Duchenne muscular dystrophy.

P R Clemens1, P A Ward, C T Caskey

  • 1Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.

Neurology
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A ZPR1 mutation is associated with a novel syndrome of growth restriction, distinct craniofacial features, alopecia, and hypoplastic kidneys.

Clinical genetics·2018
Same author

Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 families.

Clinical genetics·2017
Same author

Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.

Clinical genetics·2015
Same author

LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tongues.

Clinical genetics·2015
Same author

Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study.

Clinical genetics·2014
Same author

Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy.

Clinical genetics·2013
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

A premature chain termination mutation was found in two brothers with Duchenne muscular dystrophy. This mutation, affecting dystrophin, suggests the C-terminal region may not be essential for its membrane localization.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuromuscular Disorders

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
  • DMD is caused by mutations in the dystrophin gene.
  • Understanding mutation types is crucial for DMD research.

Observation:

  • Identified a premature chain termination mutation in two brothers with DMD.
  • Southern and PCR studies revealed no major gene rearrangements.
  • A point mutation creating a new HindIII restriction site in exon 48 was detected.

Findings:

  • Direct DNA sequencing confirmed a C-to-T transition at nucleotide 7163 of dystrophin.
  • This mutation converts a glutamine codon to an ochre chain termination codon.
  • The mutation predicts a truncated dystrophin lacking key domains.

Related Experiment Videos

Implications:

  • The C-terminal region of dystrophin may not be essential for membrane localization.
  • Immunohistochemistry showed dystrophin membrane localization despite the mutation.
  • Rare fibers exhibited peripheral immunostaining, suggesting gene reversion or read-through.